Thus we treated ADPKD and OX161 cells with PLD1 and PLD2 inhibitors and examined their effect on the phosphorylation of the up- and down-stream targets of the mTOR pathway. The gene discussed is PLD1; the disease is autosomal dominant polycystic kidney disease.